141 related articles for article (PubMed ID: 11174203)
1. Human epidermal Langerhans' cells are targets for the immunosuppressive macrolide tacrolimus (FK506).
Panhans-Gross A; Novak N; Kraft S; Bieber T
J Allergy Clin Immunol; 2001 Feb; 107(2):345-52. PubMed ID: 11174203
[TBL] [Abstract][Full Text] [Related]
2. Tacrolimus and TGF-beta act synergistically on the generation of Langerhans cells.
Kwiek B; Peng WM; Allam JP; Langner A; Bieber T; Novak N
J Allergy Clin Immunol; 2008 Jul; 122(1):126-32, 132.e1. PubMed ID: 18547634
[TBL] [Abstract][Full Text] [Related]
3. Tacrolimus ointment causes inflammatory dendritic epidermal cell depletion but no Langerhans cell apoptosis in patients with atopic dermatitis.
Schuller E; Oppel T; Bornhövd E; Wetzel S; Wollenberg A
J Allergy Clin Immunol; 2004 Jul; 114(1):137-43. PubMed ID: 15241357
[TBL] [Abstract][Full Text] [Related]
4. Topical tacrolimus (FK506) leads to profound phenotypic and functional alterations of epidermal antigen-presenting dendritic cells in atopic dermatitis.
Wollenberg A; Sharma S; von Bubnoff D; Geiger E; Haberstok J; Bieber T
J Allergy Clin Immunol; 2001 Mar; 107(3):519-25. PubMed ID: 11240954
[TBL] [Abstract][Full Text] [Related]
5. Functional CD86 (B7-2/B70) is predominantly expressed on Langerhans cells in atopic dermatitis.
Ohki O; Yokozeki H; Katayama I; Umeda T; Azuma M; Okumura K; Nishioka K
Br J Dermatol; 1997 Jun; 136(6):838-45. PubMed ID: 9217814
[TBL] [Abstract][Full Text] [Related]
6. Triptolide inhibits proinflammatory factor-induced over-expression of class II MHC and B7 molecules in renal tubular epithelial cells.
Li H; Liu ZH; Dai CS; Liu D; Li LS
Acta Pharmacol Sin; 2002 Sep; 23(9):775-81. PubMed ID: 12230943
[TBL] [Abstract][Full Text] [Related]
7. Topical FK506 suppresses cytokine and costimulatory molecule expression in epidermal and local draining lymph node cells during primary skin immune responses.
Homey B; Assmann T; Vohr HW; Ulrich P; Lauerma AI; Ruzicka T; Lehmann P; Schuppe HC
J Immunol; 1998 Jun; 160(11):5331-40. PubMed ID: 9605132
[TBL] [Abstract][Full Text] [Related]
8. Human epidermal Langerhans cells differ from monocyte-derived Langerhans cells in CD80 expression and in secretion of IL-12 after CD40 cross-linking.
Peiser M; Wanner R; Kolde G
J Leukoc Biol; 2004 Sep; 76(3):616-22. PubMed ID: 15178702
[TBL] [Abstract][Full Text] [Related]
9. Skin application of the nonsteroidal anti-inflammatory drug ketoprofen downmodulates the antigen-presenting ability of Langerhans cells in mice.
Atarashi K; Kabashima K; Akiyama K; Tokura Y
Br J Dermatol; 2008 Aug; 159(2):306-13. PubMed ID: 18565185
[TBL] [Abstract][Full Text] [Related]
10. Low-dose UVB radiation perturbs the functional expression of B7.1 and B7.2 co-stimulatory molecules on human Langerhans cells.
Weiss JM; Renkl AC; Denfeld RW; de Roche R; Spitzlei M; Schöpf E; Simon JC
Eur J Immunol; 1995 Oct; 25(10):2858-62. PubMed ID: 7589083
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of Langerhans cells with ketoprofen plus UVA in murine photocontact dermatitis to ketoprofen.
Atarashi K; Kabashima K; Akiyama K; Tokura Y
J Dermatol Sci; 2007 Aug; 47(2):151-9. PubMed ID: 17512174
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of human epidermal Langerhans' cell B7-1 and B7-2 co-stimulatory molecules in vivo by solar-simulating irradiation.
Laihia JK; Jansen CT
Eur J Immunol; 1997 Apr; 27(4):984-9. PubMed ID: 9130654
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of cytokines and immunosuppressive drugs on CD40, B7-1, and B7-2 expression on purified epidermal Langerhans cells1.
Salgado CG; Nakamura K; Sugaya M; Tada Y; Asahina A; Fukuda S; Koyama Y; Irie S; Tamaki K
J Invest Dermatol; 1999 Dec; 113(6):1021-7. PubMed ID: 10594746
[TBL] [Abstract][Full Text] [Related]
14. Interferon-gamma differentially regulates CD80 (B7-1) and CD86 (B7-2/B70) expression on human Langerhans cells.
Yokozeki H; Katayama I; Ohki O; Arimura M; Takayama K; Matsunaga T; Satoh T; Umeda T; Azuma M; Okumura K; Nishioka K
Br J Dermatol; 1997 Jun; 136(6):831-7. PubMed ID: 9217813
[TBL] [Abstract][Full Text] [Related]
15. Pimecrolimus leads to an apoptosis-induced depletion of T cells but not Langerhans cells in patients with atopic dermatitis.
Hoetzenecker W; Ecker R; Kopp T; Stuetz A; Stingl G; Elbe-Bürger A
J Allergy Clin Immunol; 2005 Jun; 115(6):1276-83. PubMed ID: 15940147
[TBL] [Abstract][Full Text] [Related]
16. Cilomilast, tacrolimus and rapamycin modulate dendritic cell function in the elicitation phase of allergic contact dermatitis.
Bäumer W; Sülzle B; Weigt H; De Vries VC; Hecht M; Tschernig T; Kietzmann M
Br J Dermatol; 2005 Jul; 153(1):136-44. PubMed ID: 16029339
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of HLA class II and costimulatory CD86/B7-2 on circulating monocytes from melanoma patients.
Ugurel S; Uhlig D; Pföhler C; Tilgen W; Schadendorf D; Reinhold U
Cancer Immunol Immunother; 2004 Jun; 53(6):551-9. PubMed ID: 14727087
[TBL] [Abstract][Full Text] [Related]
18. Novel characterization of MHC class II-negative population of resident corneal Langerhans cell-type dendritic cells.
Hamrah P; Zhang Q; Liu Y; Dana MR
Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):639-46. PubMed ID: 11867578
[TBL] [Abstract][Full Text] [Related]
19. Pimecrolimus -- an anti-inflammatory drug targeting the skin.
Grassberger M; Steinhoff M; Schneider D; Luger TA
Exp Dermatol; 2004 Dec; 13(12):721-30. PubMed ID: 15560755
[TBL] [Abstract][Full Text] [Related]
20. Enhanced expression of B7.2 (CD86) in patients with atopic dermatitis: a potential role in the modulation of IgE synthesis.
Jirapongsananuruk O; Hofer MF; Trumble AE; Norris DA; Leung DY
J Immunol; 1998 May; 160(9):4622-7. PubMed ID: 9574570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
